Stockreport

Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54% [Yahoo! Finance]

Sunshine Biopharma Inc.  (SBFM) 
NASDAQ:AMEX Investor Relations: sunshinebiopharma.com/press-releases.html
PDF life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2024 first quarter report with the Securi [Read more]